Skip to content

EULAR Impact of Rheumatic and Musculoskeletal Diseases Survey

EULAR Impact of Rheumatic and Musculoskeletal Diseases Survey

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06461000
Acronym
ImpactSurvey
Enrollment
1000
Registered
2024-06-14
Start date
2025-06-12
Completion date
2029-06-12
Last updated
2025-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases, Rheumatologic Disease

Brief summary

The EULAR Impact of RMDs Survey collects first-hand information about the impact of rheumatic and musculoskeletal diseases (RMDs) among patients across and beyond Europe. Through periodic questionnaires, patients will provide information about their healthcare situation, and how the disease affects their social and occupational lives. This data will be an important resource for researchers, healthcare professionals, and patients alike, providing valuable insights into the burden of disease and helping improve the overall care for people living with these conditions.

Interventions

OTHERSurvey

online survey for participants

Sponsors

European Alliance of Associations in Rheumatology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18-year-old at time of baseline survey * Living in a EULAR country at time of baseline survey * Diagnosed with at least one RMD * Valid personal e-mail address * Being able to use an internet website

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
General population description - countryevery 6 months for up to 5 yearscountry of residence
General population description - diagnosisevery 6 months for up to 5 yearsdiagnosis (name of the disease)
General population descriptionevery 6 months for up to 5 yearsyear of birth

Secondary

MeasureTime frameDescription
Diagnosis history - Inpatient careevery 6 months for up to 5 yearsnumber of days of hospitalization during the past 6 months.
Non-pharmacological and pharmacological treatments.every 6 months for up to 5 yearsNames of medications taken by the patients (from a list)
Other chronic diseasesevery 6 months for up to 5 yearsdiagnosis of chronic diseases other than RMD and medication taken for these conditions.
Disease burden - impact of diseaseevery 6 months for up to 5 yearsRheumatic Arthritis Impact of Disease (RAID) version 7 questionnaire. The RAID is calculated based on 7 Numerical rating scales (NRS) questions. Each NRS is assessed as a number between 0 and 10. The 7 NRS correspond to pain, function, fatigue, sleep, emotional well-being, physical well-being, and coping/self-efficacy. The range of the final RAID value is 0-10 where higher figures indicate worse status.
Disease burden - health assessmentevery 6 months for up to 5 yearsHealth assessment questionnaire version 2 (HAQ2). The HAQ comprises of 20 questions covering 20 daily activities. These are divided in eight domains: dressing and grooming, rising, eating, walking, hygiene, reaching, gripping, and other activities. Each question is scored according to a four-point scale (0-3), and the highest scores from each domain are summed and divided by eight, to derive a total HAQ score, which ranges from 0 to 3 (3 = highest level of disability).
Diagnosis history - physician treating the RMDevery 6 months for up to 5 yearsPrimary physician specialty treating the patient
Consequences on work and life (WPAI questionnaire)every 6 months for up to 5 yearswork productivity and activity impairment questionnaire (WPAI), including total number of sick leave days due to RMD in the past 6 months. Final score is calculated in % higher scores on the WPAI indicate worse outcomes
Other barriers due to RMDevery 6 months for up to 5 yearsimpact on family, leisure, social and work activities (quality of life questionnaire)
Health careevery 6 months for up to 5 yearssupport from professionals (general questionnaire), satisfaction with care (scale, 1= low, 5 = high satisfaction)
Demographics - persons living with patientevery 6 months for up to 5 yearsnumber of persons living in household
Demographics - professional statusevery 6 months for up to 5 yearsprofessional status
Disease burden - quality of lifeevery 6 months for up to 5 yearspatient health questionnaire (PHQ-8). The PHQ-8 is a self-reported measure of depressive symptoms composed of 8 Likert type items with a response scale ranging from 0 (Not at all) to 3 (Nearly every day), that refer to the presence of that symptom during the previous 2 weeks.Each item corresponds to the first 8 symptoms of the 4th edition of the DSM-IV diagnostic criteria for major depressive disorder. The PHQ-8 final score is obtained by adding the score for each of the items, ranging from 0 to 24 (higher scores corresponding to higher levels of depression).
Diagnosis history - outpatient care historyevery 6 months for up to 5 yearsnumber of medical appointments for the past 6 months
Diagnosis history - timelineevery 6 months for up to 5 yearswaiting time for medical appointments and time spent in medical appointments

Countries

Switzerland

Contacts

Primary ContactCoralie Signorell, PhD
coralie.signorell@eular.org0445751564
Backup ContactCarina Haupt
carina.haupt@eular.org+41 44 716 30 46

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026